Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee

NCT00988091 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DEVICE: 1.2% Sodium Hyaluronate
DEVICE: Buffered Saline

Sponsor

Ferring Pharmaceuticals